The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
Dz13 Drug Targets Skin Cancer In Clinical Trial
A new class of drug has been found to be safe in a clinical trial of patients with the common skin cancer, basal-cell carcinoma.
Clinical Trial Uses South Pacific Plant Kava To Treat Anxiety
An Australian clinical study has shown that Kava, a medicinal South Pacific plant, significantly reduced the symptoms of people suffering from anxiety.
ScinoPharm, Coland Holdings To Co-Develop Generic Oncologic Drugs
ScinoPharm Taiwan Ltd. and Coland Holdings Ltd. announced this week a strategic alliance to develop a series of generic oncological drugs for Mainland China.
Sagent Pharma To Acquire Remaining Interest In Chengdu Kanghong Pharma
U.S. biotech Sagent Pharma will acquire the remaining 50 percent interest of the Kanghong Sagent (Chengdu) Pharmaceutical Corporation Limited joint venture.
A*STAR, Oxford Biodynamics Partner On Stem Cell Research
A*STAR and Oxford Biodynamics have agreed to collaborate on a project to identify epigenetic signatures in stem cells.
Detecting Toxic Orange II Dye That Gives Ketchup Its Red Hue
Scientists in China have developed an electrochemical method to spot the dangerous Orange II dye in condiments such as ketchup and chilli.
Printing Flexible Electronic Circuits On Paper
Scientists in China have developed a method to print flexible electronic circuits on paper using liquid metal ink.
Taiwan & Mexico Launch Astronomical Observation Project, TAOS-2
A collaboration between Taiwan and Mexico aims to build a new observatory in California that will study the Solar System beyond Neptune.
Glaxo & Taiwan’s NRPB Sign Clinical Trial Research Pact
Taiwan's National Research Program for Biopharmaceuticals signed yesterday an MOU with GlaxoSmithKline to develop Taiwan as a clinical trial hub in Asia.